Macrobian Biotech logo

Macrobian Biotech

Towards Novel Treatments for Parkinson's Disease

3 employees · est. 2017 · Amsterdam, The Netherlands

VS
UCB logo

UCB

We’re #TeamUCB, a global biopharmaceutical company. 💙 Inspired by patients 🔬 Driven by science

14960 employees · est. 1928 · Brussels, Belgium

UCB is the older company (2017 vs 1928); UCB is the larger of the two.

Side-by-Side Comparison

Macrobian Biotech UCB
Founded
2017 1928 older
Headquarters
Amsterdam, The Netherlands Brussels, Belgium
Employees
3 14960 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Pharmaceutical
Funding Stage
Pre Seed IPO
Total Funding
Not tracked yet $194.50M
Funding Rounds
2 5
Services
Not tracked yet Personalized patient support, Clinical studies, Drug development and innovation, Healthcare professional collaboration, Scientific publications
Target Customers
Not tracked yet Patients with neurological disorders, Patients with autoimmune diseases, Healthcare professionals, Women of childbearing age
Taxonomy
Neuroscience, Drug Development, Parkinson's Disease, Molecular Research, Innovative Treatments, Academic Excellence, Netherlands, Science Park, Startup, Neurological Disorders, Medical Research, Quality Of Life, Innovation, Founders Biopharmaceutical Company, Patient-centered Solutions, Central Nervous System, Immunological Conditions, Innovative Healthcare, Clinical Outcomes, Transformative Science, Epilepsy Research, Parkinson's Disease, Crohn's Disease, Neurology Research, Immunology Research, Global Collaboration, Healthcare Partnerships, Cutting-edge Research
Website
macrobianbiotech.com ucb.com
Macrobian Biotech logo

About Macrobian Biotech

Macrobian Biotech is a biotechnology startup founded in May 2017 with a mission to advance the field of molecular neuroscience and develop innovative treatments for Parkinson's disease. Founded by Dr. Lars van der Heide and Prof. dr. Marten Smidt, both possessing extensive experience in the field, t...

UCB logo

About UCB

UCB is a seasoned player in the biopharmaceutical industry, having been established in 1928. Headquartered in Belgium, this global company is dedicated to creating innovative solutions for those living with severe central nervous system and immunological conditions. With the slogan "We’re #TeamUCB,...

We will tell you when either one moves

BounceWatch watches Macrobian Biotech and UCB for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Macrobian Biotech and UCB — by email.

Frequently Asked Questions

Macrobian Biotech — Towards Novel Treatments for Parkinson's Disease. UCB — We’re #TeamUCB, a global biopharmaceutical company. 💙 Inspired by patients 🔬 Driven by science. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Macrobian Biotech has raised undisclosed funding while UCB has raised $194.50M.
Macrobian Biotech and UCB operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Macrobian Biotech with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Macrobian Biotech on 12 Sep 2024, and UCB on 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy